Package 0173-0893-61

Brand: trelegy ellipta

Generic: fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
NDC Package Sample

Package Facts

Identity

Package NDC 0173-0893-61
Digits Only 0173089361
Product NDC 0173-0893
Product ID 0173-0893_3adf47cb-c3b5-4fdb-9441-d90679b79687
Description

1 TRAY in 1 CARTON (0173-0893-61) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER

Marketing

Marketing Status
Marketed Since 2020-09-09
Brand trelegy ellipta
Generic fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
Sample Package Yes

Linked Drug Pages (1)

Trelegy Ellipta ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "3adf47cb-c3b5-4fdb-9441-d90679b79687", "openfda": {"unii": ["JS86977WNV", "7AN603V4JV", "40AHO2C6DG"], "rxcui": ["1945039", "1945044", "1945047", "1945048", "2395769", "2395771", "2395774", "2395775"], "spl_set_id": ["b5a81d5a-4648-4c7a-951d-33c014a63c7e"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (0173-0893-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER", "package_ndc": "0173-0893-10", "marketing_start_date": "20200909"}, {"sample": false, "description": "1 TRAY in 1 CARTON (0173-0893-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER", "package_ndc": "0173-0893-14", "marketing_start_date": "20200909"}, {"sample": true, "description": "1 TRAY in 1 CARTON (0173-0893-61)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER", "package_ndc": "0173-0893-61", "marketing_start_date": "20200909"}], "brand_name": "Trelegy Ellipta", "product_id": "0173-0893_3adf47cb-c3b5-4fdb-9441-d90679b79687", "dosage_form": "POWDER", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0173-0893", "generic_name": "fluticasone furoate, umeclidinium bromide and vilanterol trifenatate", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trelegy Ellipta", "active_ingredients": [{"name": "FLUTICASONE FUROATE", "strength": "200 ug/1"}, {"name": "UMECLIDINIUM BROMIDE", "strength": "62.5 ug/1"}, {"name": "VILANTEROL TRIFENATATE", "strength": "25 ug/1"}], "application_number": "NDA209482", "marketing_category": "NDA", "marketing_start_date": "20200909", "listing_expiration_date": "20261231"}